NORWOOD, Mass.--(BUSINESS WIRE)--Apogee Technology, Inc. (AMEX: ATA), an emerging micro-systems and nanotechnology company that designs, develops and commercializes medical devices and sensor products, announced today that it has filed five U.S. provisional patent applications related to its PyraDerm™ intradermal drug delivery system. Three of the new patent applications pursue the protection of methods and compositions for specific biomedical applications and two of the patent applications pertain to novel drug delivery formulations for biomedical devices and associated microfabrication processes.
